skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study

Levy, Mitchell M, Prof ; Artigas, Antonio, Prof ; Phillips, Gary S, MAS ; Rhodes, Andrew, MBBS ; Beale, Richard, MBBS ; Osborn, Tiffany, MD ; Vincent, Jean-Louis, Prof ; Townsend, Sean, MD ; Lemeshow, Stanley, Prof ; Dellinger, R Phillip, Prof

The Lancet infectious diseases, 2012-12, Vol.12 (12), p.919-924 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Eron, Joseph J, Prof ; Rockstroh, Jürgen K, MD ; Reynes, Jacques, Prof ; Andrade-Villanueva, Jaime, MD ; Ramalho-Madruga, Jose Valdez, MD ; Bekker, Linda-Gail, MD ; Young, Benjamin, MD ; Katlama, Christine, MD ; Gatell-Artigas, Jose Maria, MD ; Arribas, Jose R, MD ; Nelson, Mark, MD ; Campbell, Havilland, BS ; Zhao, Jing, PhD ; Rodgers, Anthony J, MS ; Rizk, Matthew L, PhD ; Wenning, Larissa, PhD ; Miller, Michael D, PhD ; Hazuda, Daria, PhD ; DiNubile, Mark J, MD ; Leavitt, Randi, MD ; Isaacs, Robin, MD ; Robertson, Michael N, MD ; Sklar, Peter, MD ; Nguyen, Bach-Yen, Dr

The Lancet infectious diseases, 2011-12, Vol.11 (12), p.907-915 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis
The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis

Levy, Mitchell M ; Dellinger, R Phillip ; Townsend, Sean R ; Linde-Zwirble, Walter T ; Marshall, John C ; Bion, Julian ; Schorr, Christa ; Artigas, Antonio ; Ramsay, Graham ; Beale, Richard ; Parker, Margaret M ; Gerlach, Herwig ; Reinhart, Konrad ; Silva, Eliezer ; Harvey, Maurene ; Regan, Susan ; Angus, Derek C

Critical care medicine, 2010-02, Vol.38 (2), p.367-374 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial

Vincent, Jean-Louis ; Angus, Derek C ; Artigas, Antonio ; Kalil, Andre ; Basson, Bruce R ; Jamal, Hassan H ; Johnson, Gerald ; Bernard, Gordon R

Critical care medicine, 2003-03, Vol.31 (3), p.834-840 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Sax, Paul E, Dr Prof ; Wohl, David, MD ; Yin, Michael T, Prof ; Post, Frank, MD ; DeJesus, Edwin, MD ; Saag, Michael, MD ; Pozniak, Anton, MD ; Thompson, Melanie, MD ; Podzamczer, Daniel, MD ; Molina, Jean Michel, Prof ; Oka, Shinichi, MD ; Koenig, Ellen, MD ; Trottier, Benoit, MD ; Andrade-Villanueva, Jaime, MD ; Crofoot, Gordon, MD ; Custodio, Joseph M, PharmD ; Plummer, Andrew, MS ; Zhong, Lijie, PhD ; Cao, Huyen, MD ; Martin, Hal, MD ; Callebaut, Christian, PhD ; Cheng, Andrew K, MD ; Fordyce, Marshall W, MD ; McCallister, Scott, MD

The Lancet (British edition), 2015-06, Vol.385 (9987), p.2606-2615 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment

Vincent, Jean-Louis ; Bernard, Gordon R ; Beale, Richard ; Doig, Christopher ; Putensen, Christian ; Dhainaut, Jean-Francois ; Artigas, Antonio ; Fumagalli, Roberto ; Macias, William ; Wright, Theressa ; Wong, Kar ; Sundin, David P ; Turlo, Mary Ann ; Janes, Jonathan

Critical care medicine, 2005-10, Vol.33 (10), p.2266-2277 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis
Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis

Wernly, Bernhard ; Bruno, Raphael Romano ; Kelm, Malte ; Boumendil, Ariane ; Morandi, Alessandro ; Andersen, Finn H ; Artigas, Antonio ; Finazzi, Stefano ; Cecconi, Maurizio ; Christensen, Steffen ; Faraldi, Loredana ; Lichtenauer, Michael ; Muessig, Johanna M ; Marsh, Brian ; Moreno, Rui ; Oeyen, Sandra ; Öhman, Christina Agvald ; Pinto, Bernado Bollen ; Soliman, Ivo W ; Szczeklik, Wojciech ; Niederseer, David ; Valentin, Andreas ; Watson, Ximena ; Leaver, Susannah ; Boulanger, Carole ; Walther, Sten ; Schefold, Joerg C ; Joannidis, Michael ; Nalapko, Yuriy ; Elhadi, Muhammed ; Fjølner, Jesper ; Zafeiridis, Tilemachos ; De Lange, Dylan W ; Guidet, Bertrand ; Flaatten, Hans ; Jung, Christian

Scientific reports, 2020-10, Vol.10 (1), p.18671-18671, Article 18671 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Eron, Joseph J, Prof ; Cooper, David A, Prof ; Steigbigel, Roy T, Prof ; Clotet, Bonaventura, MD ; Gatell, Jose M, Prof ; Kumar, Princy N, Prof ; Rockstroh, Jurgen K, Prof ; Schechter, Mauro, Prof ; Markowitz, Martin, Prof ; Yeni, Patrick, MD ; Loutfy, Mona R, MD ; Lazzarin, Adriano, Prof ; Lennox, Jeffrey L, Prof ; Strohmaier, Kim M, BS ; Wan, Hong, MS ; Barnard, Richard JO, PhD ; Nguyen, Bach-Yen T, MD ; Teppler, Hedy, MD

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis
Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis

Bernard, Gordon ; Artigas, Antonio ; Dellinger, Philip ; Esmon, Charles ; Faist, Eugen ; Faust, Saul N ; Fisher, Charles J ; Fumagalli, Roberto ; Grinnell, Brian W ; Sprung, Charles

Critical care medicine, 2001-07, Vol.29 (7 Suppl 1), p.S75-S77 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2003  (1)
  2. 2003Até2004  (1)
  3. 2005Até2009  (1)
  4. 2010Até2011  (2)
  5. Após 2011  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.